Elahi Najafi, M.A.; Yasui, M.; Teramoto, Y.; Tatenuma, T.; Jiang, G.; Miyamoto, H.
GABBR2 as a Downstream Effector of the Androgen Receptor Induces Cisplatin Resistance in Bladder Cancer. Int. J. Mol. Sci. 2023, 24, 13733.
https://doi.org/10.3390/ijms241813733
AMA Style
Elahi Najafi MA, Yasui M, Teramoto Y, Tatenuma T, Jiang G, Miyamoto H.
GABBR2 as a Downstream Effector of the Androgen Receptor Induces Cisplatin Resistance in Bladder Cancer. International Journal of Molecular Sciences. 2023; 24(18):13733.
https://doi.org/10.3390/ijms241813733
Chicago/Turabian Style
Elahi Najafi, Mohammad Amin, Masato Yasui, Yuki Teramoto, Tomoyuki Tatenuma, Guiyang Jiang, and Hiroshi Miyamoto.
2023. "GABBR2 as a Downstream Effector of the Androgen Receptor Induces Cisplatin Resistance in Bladder Cancer" International Journal of Molecular Sciences 24, no. 18: 13733.
https://doi.org/10.3390/ijms241813733
APA Style
Elahi Najafi, M. A., Yasui, M., Teramoto, Y., Tatenuma, T., Jiang, G., & Miyamoto, H.
(2023). GABBR2 as a Downstream Effector of the Androgen Receptor Induces Cisplatin Resistance in Bladder Cancer. International Journal of Molecular Sciences, 24(18), 13733.
https://doi.org/10.3390/ijms241813733
